ATR |
Q13535
|
ATR serine/threonine kinase
|
Kinase
|
3.5E-09 |
0.456 |
0.923 |
ATN1 |
P54259
|
atrophin 1
|
|
1.00 |
0.409 |
0.885 |
AURKA |
O14965
|
aurora kinase A
|
Kinase
|
0.87 |
0.475 |
0.731 |
AURKB |
Q96GD4
|
aurora kinase B
|
Kinase
|
4.5E-03 |
0.510 |
0.769 |
BTLA |
Q7Z6A9
|
B and T lymphocyte associated
|
|
2.1E-02 |
0.593 |
0.577 |
BRAF |
P15056
|
B-Raf proto-oncogene, serine/threonine kinase
|
Kinase
|
1.00 |
0.319 |
0.846 |
BCL10 |
O95999
|
BCL10 immune signaling adaptor
|
|
0.34 |
0.491 |
0.769 |
BCL2 |
P10415
|
BCL2 apoptosis regulator
|
Signaling
|
0.56 |
0.291 |
0.885 |
BAX |
Q07812
|
BCL2 associated X, apoptosis regulator
|
Signaling
|
0.32 |
0.417 |
0.885 |
BIK |
Q13323
|
BCL2 interacting killer
|
|
5.0E-06 |
0.653 |
0.462 |
BNIP3L |
O60238
|
BCL2 interacting protein 3 like
|
|
0.15 |
0.636 |
0.654 |
BCL2L11 |
O43521
|
BCL2 like 11
|
|
0.89 |
0.510 |
0.731 |
BCL6 |
P41182
|
BCL6 transcription repressor
|
|
0.96 |
0.444 |
0.808 |
BCR |
P11274
|
BCR activator of RhoGEF and GTPase
|
Enzyme modulator
|
0.99 |
0.431 |
0.885 |
B2M |
P61769
|
beta-2-microglobulin
|
Immune response
|
0.56 |
0.447 |
0.846 |
BMI1 |
P35226
|
BMI1 proto-oncogene, polycomb ring finger
|
|
0.94 |
0.448 |
0.808 |
BMS1P20 |
|
BMS1 pseudogene 20
|
|
|
0.682 |
0.577 |
BMP7 |
P18075
|
bone morphogenetic protein 7
|
Signaling
|
0.13 |
0.498 |
0.769 |
BRD4 |
O60885
|
bromodomain containing 4
|
Epigenetic regulator
|
1.00 |
0.446 |
0.885 |
BTK |
Q06187
|
Bruton tyrosine kinase
|
Kinase
|
1.00 |
0.464 |
0.808 |
BACH2 |
Q9BYV9
|
BTB domain and CNC homolog 2
|
|
1.00 |
0.539 |
0.731 |
CCL3 |
P10147
|
C-C motif chemokine ligand 3
|
Signaling
|
0.35 |
0.460 |
0.885 |
CCR5 |
P51681
|
C-C motif chemokine receptor 5 (gene/pseudogene)
|
G-protein coupled receptor
|
4.3E-10 |
0.398 |
0.885 |
CCR7 |
P32248
|
C-C motif chemokine receptor 7
|
G-protein coupled receptor
|
5.8E-02 |
0.443 |
0.769 |
CRP |
P02741
|
C-reactive protein
|
|
3.7E-03 |
0.299 |
0.962 |